500
Participants
Start Date
July 16, 2019
Primary Completion Date
February 29, 2024
Study Completion Date
February 29, 2024
Research Site, Beijing
Research Site, Beijing
Research Site, Changchun
Research Site, Shanghai
Research Site, Shanghai
Research Site, Hefei
Research Site, Shijiazhuang
Research Site, Nanning
Research Site, Chengdu
Research Site, Chengdu
Research Site, Yinchuan
Research Site, Jinan
Research Site, Beijing
Research Site, Datong
Research Site, Fenyang
Research Site, Guangzhou
Research Site, Qingdao
Research Site, Shantou
Research Site, Taizhou
Research Site, Tianjin
Research Site, Hong Kong
Research Site, Shanghai
Research Site, Datong
Research Site, Shijiazhuang
Research Site, Shijiazhuang
Lead Sponsor
AstraZeneca
INDUSTRY